192. Маевская, Е. А. Синдром избыточного бактериального роста в тонкой кишке: от последних научных данных к рутинной практике / Е. А. Маевская, С. В. Черемушкин, Н. А. Кривобородов, Ю. А. Кучерявый // Клиничексие перспективы гастроэнтерологии, гепатологии. – 2013. – № 5. – С. 29–40.
193. Sabaté, J. M. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis / J. M. Sabaté, P. Jouët, F. Harnois et al. // Obes. Surg. – 2008. – Vol. 18. – P. 371–377.
194. Lo, W. K. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis / W. K. Lo, W. W. Chan // Clin. Gastroenterol. Hepatol. – 2013. – Vol. 11 (5). – P. 483–490.
195. Ratuapli, S. K. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth / S. K. Ratuapli, T. G. Ellington, M. T. O’Neill et al. // Am. J. Gastroenterol. – 2012. – Vol. 107 (5). – P. 730–735.
196. Choung, R. S. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture / R. S. Choung, K. C. Ruff, A. Malhotra et al. // Aliment. Pharmacol. Ther. – 2011. – Vol. 33 (9). – P. 1059–1067.
197. Shah, E. D. Abnormal Breath Testing in IBS: A MetaAnalysis / E. D. Shah, R. J. Basseri, K. Chong, M. Pimentel // Dig. Dis. Sci. – 2010. – Vol. 55 (9). – P. 2441–2449.
198. Castiglione, F. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease / F. Castiglione, A. Rispo, E. Di Girolamo et al. // Aliment. Pharmacol. Ther. – 2003. – Vol. 18. – P. 1107–1112.
199. Ghoshal, U. C. Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance / U. C. Ghoshal, U. Ghoshal, A. Misra, G. Choudhuri // BMC. Gastroenterol. – 2004. – Vol. 4. – P. 10.
200. Krauss, N. Monitoring nonresponsive patients who have celiac disease / N. Krauss, D. Schuppan // Gastrointest. Endosc. Clin. N. Am. – 2006. – Vol. 16. – P. 317–327.
201. Trespi, E. Intestinal bacterial overgrowth during chronic pancreatitis / E. Trespi, A. Ferrieri // Curr. Med. Res. Opin. – 1999. – Vol. 15. – P. 47–52.
202. Malik, B. A. Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure / B. A. Malik, Y. Y. Xie, E. Wine, H. Q. Huynh // Can. J. Gastroenterol. – 2011. – Vol. 25 (1). – P. 41–45.
203. Bauer, T. M. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia / T. M. Bauer, H. Schwacha, B. Steinbrückner.et al. // Am. J. Gastroenterol. – 2002. – Vol. 97. – P. 2364–370.
204. Chang, C. S. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis / C. S. Chang, G. H. Chen, H. C. Lien, H. Z. Yeh // Hepatology. – 1998. – Vol. 28. – P. 1187–1190.
205. Lata, J. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis / J. Lata, O. Stiburek, M. Kopacova // Wld. J. Gastroenterol. – 2009. – Vol. 15. – P. 5505–5510.
206. Pande, C. Smallintestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease / C. Pande, A. Kumar, S. K. Sarin // Aliment. Pharmacol. Ther. – 2009. – Vol. 29. – P. 1273–1281.
207. Sánchez, E. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis / E. Sánchez, F. Casafont, A. Guerra et al. // Rev. Esp. Enferm. Di g. –2005. – Vol. 97 (11). – P. 805–814.
208. Jun, D. W. Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients / D. W. Jun, K. T. Kim, O. Y. Lee et al. // Dig. Dis. Sci. – 2010. – Vol. 55 (5). – P. 1465–1471.
209. Bellot, P. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications / P. Bellot, R. Francés, J. Such // Liver Int. – 2013. – Vol. 33 (1). – P. 31–39.
210. Wu, W. C. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats / W. C. Wu, W. Zhao, S. Li // Wld. J. Gastroenterol. – 2008. – Vol. 14. – P. 313–317.
211. Wigg, A. J. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, andtumour necrosis factor alpha in the pathogenesis of nonalcoholic steatohepatitis / A. J. Wigg, I. C. Roberts-Thomson, R. B. Dymock et al. // Gut. – 2001. – Vol. 48. – P. 206–211.
212. Sajjad, A. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis / A. Sajjad, M. Mottershead, W. K. Syn et al. // Aliment. Pharmacol. Ther. – 2005. – Vol. 22. – P. 291–299.
213. Fan, X. Review article: Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea / X. Fan, J. H. Sellin // Aliment. Pharmacol. Ther. – 2009. – Vol. 29. – P. 1069–1077.
214. Gasbarrini, A. Small intestinal bacterial overgrowth: diagnosis and treatment / A. Gasbarrini, E. C. Lauritano, M. Gabrielli et al. // Dig. Dis. Sci. – 2007. – Vol. 25. – P. 237–240.
215. Malik, B. A. Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure / B. A. Malik, Y. Y. Xie, E. Wine, H. Q. Huynh // Can. J. Gastroenterol. – 2011. – Vol. 25 (1). – P. 41–45.
216. Nelis, G. F. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome / G. F. Nelis, M. A. Vermeeren, W. Jansen // Gastroenterology. – 1990. – Vol. 99. – P. 1016–1020.
217. Nucera, G. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth / G. Nucera, M. Gabrielli, A. Lupascu. et al. // Aliment. Pharmacol. Ther. – 2005. – Vol. 21. – P. 1391–1395.
218. Bohm, M. Diagnosis and management of small intestinal bacterial overgrowth / M. Bohm, R. M. Siwiec, J. M. Wo // Nutr. Clin. Pract. – 2013. – Vol. 28 (3). – P. 289–299.
219. Khoshini, R. A systematic review of diagnostic tests for small intestinal bacterial overgrowth / R. Khoshini, S. C. Dai, S. Lezcano, M. Pimentel // Dig. Dis. Sci. – 2008. – Vol. 53. – P. 1443–1454.
220. Bures, J. Small intestinal bacterial overgrowth syndrome / J. Bures, J. Cyrany, D. Kohoutova et al. // Wld. J. Gastroenterol. – 2010. – Vol. 28. – P. 2978–2990.
221. Dibaise, J. K. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome / J. K. Dibaise, R. J. Young, J. A. Vanderhoof // Clin. Gastroenterol. Hepatol. – 2006. – Vol. 4. – P. 11–20.
222. Bures, J. Small intestinal bacterial overgrowth syndrome / J. Bures, J. Cyrany, D. Kohoutova et al. // Wld. J. Gastroenterol. – 2010. – Vol. 28. – P. 2978–2990.
223. Barrett, J. S. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome / J. S. Barrett, K. E. Canale, R. B. Gearry et al. // Wld. J. Gastroenterol. – 2008. – Vol. 14 (32). – P. 5020–5024.
224. Koo, H. L. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases / H. L. Koo, H. L. DuPont // Curr. Opin. Gastroenterol. – 2010. – Vol. 26 (1). – P. 17–25.
225. Gutierrez, I. M. Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review / Ivan M. Gutierrez,, Kuang Horng Kang, Catherine E. Calvert et al. // J. Pediatr Surg. – 2012. – Vol. 47 (6). – P. 1150–1154.
226. Sondheimer, J. M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition / J. M. Sondheimer, E. Asturias, M. Cadnapaphornchai // J. Pediatr. Gastroenterol. Nutr. 1998; 27:131–7. [Pub. Med: 9702641]
227. Cole, C. R. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses / C. R. Cole, J. C. Frem, B. Schmotzer et al. // J. Pediatr. 2010; 156:941–7. 7, e1. [PubMed: 20171649]
228. Kaufman, S. S. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome / S. S. Kaufman, C. A. Loseke, J. V. Lupo et al. // J. Pediatr. 1997; 131:356–61. [PubMed: 9329409]
229. D’Antiga, L. Intestinal absorption and permeability in paediatric short-bowel syndrome: a pilot study / L. D’Antiga, A. Dhawan, M. Davenport et al. // J. Pediatr. Gastroenterol. Nutr. 1999; 29:588–93. [PubMed: 10554128]
230. Husebye, E. The pathogenesis of gastrointestinal bacterial overgrowth. / E. Husebye // Chemotherapy. 2005; 51 (Suppl 1):1–22. [PubMed: 15855746]
231. Ziegler, T. R. Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function / T. R. Ziegler, M. E. Evans, C. Fernandez-Estivariz et al. // Annu. Rev. Nutr. 2003; 23:229–61. [PubMed: 12626687]
232. Berg, R. D. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model / R. D. Berg, A. W. Garlington // Infect Immun. 1979; 23:403–11. [PubMed: 154474]
233. Berg, R. D. Bacterial translocation from the gastrointestinal tract / R. D. Berg // J. Med. 1992; 23:217–44. [PubMed: 1479301]
234. Dibaise, J. K. Enteric microbial flora, bacterial overgrowth, an.d shortbowel syndrome / J. K. Dibaise, R. J. Young,J. A. Vanderhoof // Clin Gastroenterol. Hepatol. – 2006; 4:11–20. [PubMed: 16431299]
235. Riepe, S. P. Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases / S. P. Riepe, J. Goldstein, D. H. Alpers // J. Clin. Invest. 1980; 66:314–22. [PubMed: 6995483]
236. Bala, L. Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy / L. Bala, U. C. Ghoshal, U. Ghoshal et al. // Magn Reson Med. 2006; 56:738–44. [PubMed: 16972311]
237. Sigalet, D. Elements of successful intestinal rehabilitation / D. Sigalet, D. Boctor, M. Brindle et al. // J. Pediatr. Surg. 2011; 46:150–6. [PubMed: 21238657]
238. Spiegel, B. M. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors? / B. M. Spiegel, W. D. Chey, L. Chang // Am. J. Gastroenterol. 2008; 103:2972–6. [PubMed: 19086951
239. Wei, Zh. Alterations of the gut microbiome and metabolome in alcoholic liver disease / Wei Zhong, Zhanxiang Zhou // World. J. Gastrointest Pathophysiol. – 2014. – Vol. 5 (4). – P. 514–522.
240. Casafont Morencos, F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis / F. Casafont Morencos, G. de las Heras Castaño, L. Martín // Dig. Dis. Sci. 1996; 41: 552–556 [PMID: 8617135
241. Gabbard, S. L. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth / S. L. Gabbard, B. E. Lacy, G. M. Levine, M. D. Crowell // Dig. Dis. Sci. 2014; 59: 638–644 [PMID: 24323179 DOI: 10.1007 / s10620-013-2960-y]
242. Yan, A. W. Enteric dysbiosis associated with a mouse model of alcoholic liver disease / A. W. Yan, D. E. Fouts, J. Brandl et al. // Hepatology. 2011; 53: 96–105 [PMID: 21254165 DOI: 10.1002 / hep.24018]
243. Bull-Otterson, L. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment / L. Bull-Otterson, W. Feng, I. Kirpich // PLoS One. 2013; 8: e53028 [PMID: 23326376 DOI: 10.1371 / journal.pone.0053028]
244. Bode, J. C. Jejunal microflora in patients with chronic alcohol abuse / J. C. Bode, C. Bode, R. Heidelbach et al. // Hepatogastroenterology. 1984; 31: 30–34 [PMID: 6698486]
245. Baraona, E. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats / E. Baraona, R. Julkunen, L. Tannenbaum et al. // Gastroenterology. 1986; 90: 103–110 [PMID: 3940238]
246. Väkeväinen, S. Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol / S. Väkeväinen, J. Tillonen, M. Salaspuro et al. // Aliment Pharmacol Ther. 2000; 14: 1511–1518 [PMID: 11069323]
247. Visapää, J. P. Microbes and mucosa in the regulation of intracolonic acetaldehyde concentration during ethanol challenge // J. P. Visapää, J. Tillonen, M. Salaspuro // Alcohol. 2002; 37: 322–326 [PMID: 12107032]
248. Lichtman, S. N. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth / S. N. Lichtman, R. B. Sartor, J. Keku, J. H. Schwab // Gastroenterology. 1990; 98: 414–423 [PMID: 2295397]
249. Napolitano, L. M. Chronic ethanol intake and burn injury: evidence for synergistic alteration in gut and immune integrity / L. M. Napolitano, M. J. Koruda, K. J. Zimmerman // J. Trauma. 1995; 38: 198–207 [PMID: 7869435]
250. Rao, R. K. Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease / R. K. Rao, A. Seth, P. Sheth // Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 286: G881-G884 [PMID: 15132946 DOI: 10.1152 / ajpgi.00006.2004]
251. Fujimoto, M. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance / M. Fujimoto, M. Uemura, Y. Nakatani et al. // Alcohol Clin Exp Res2000; 24: 48S-54S [PMID: 10803780]
252. Hanck, C. Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis / C. Hanck, S. Rossol, U. Böcker et al. // Alcohol Alcohol. 1998; 33: 606–608 [PMID: 9872348]
253. Urbaschek, R. Endotoxin, endotoxin-neutralizingcapacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease / R. Urbaschek, R. S. McCuskey, V. Rudi et al. // Alcohol Clin Exp Res. 2001; 25: 261–268 [PMID: 11236841]
254. Szabo, G. Alcoholic liver disease and the gutliver axis / G. Szabo, S. Bala // World J Gastroenterol. 2010; 16: 1321–1329 [PMID: 20238398]
255. Francés, R. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites / R. Francés, S. Benlloch, P. Zapater et al. // Hepatology. 2004; 39: 484–491 [PMID: 14768002 DOI: 10.1002 / hep.20055]
256. Romics, L. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice / L. Romics, A. Dolganiuc, K. Kodys et al. // Hepatology. 2004; 40: 555–564 [PMID: 15349893 DOI: 10.1002 / hep.20350]
257. Gustot, T. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver / T. Gustot, A. Lemmers, C. Moreno et al. // Hepatology. 2006; 43: 989–1000 [PMID: 16628628 DOI: 10.1002 / hep.21138]
258. Purohit, V. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium / V. Purohit, J. C. Bode, C. Bode // Alcohol. 2008; 42: 349–361 [PMID: 18504085 DOI: 10.1016 / j.alcohol.2008.03.131]
259. Bjarnason, I. The leaky gut of alcoholism: possible route of entry for toxic compounds / I. Bjarnason, T. J. Peters, R. J. Wise et al. // Lancet. 1984; 1: 179–182 [PMID: 6141332]
260. Keshavarzian, A. The differing effects of acute and chronic alcohol on gastric and intestinal permeability / A. Keshavarzian, J. Z. Fields, J. Vaeth et al. // Am J Gastroenterol. 1994; 89: 2205–2211 [PMID: 7977243]
261. Keshavarzian, A. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage / A. Keshavarzian, E. W. Holmes, M. Patel et al. // Am J Gastroenterol. 1999; 94: 200–207 [PMID: 9934756 DOI: 10.1111 / j.1572–0241.1999.00797.x]
262. Parlesak, A. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease / A. Parlesak, C. Schäfer, T. Schütz et al. // J Hepatol. 2000; 32: 742–747 [PMID: 10845660]
263. Enomoto, N. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production / N. Enomoto, Y. Takei, M. Hirose et al. // Gastroenterology. 2002; 123: 291–300 [PMID: 12105857]
264. Forsyth, C. B. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis / C. B. Forsyth, A. Farhadi, S. M. Jakate et al. // Alcohol. 2009; 43: 163–172 [PMID: 19251117 DOI: 10.1016 / j.alcohol.2008.12.009]
265. Mathurin, P. Exacerbation of alcoholic liver injury by enteral endotoxin in rats / P. Mathurin, Q. G. Deng, A. Keshavarzian et al. // Hepatology. 2000; 32: 1008–1017 [PMID: 11050051 DOI: 10.1053 / jhep.2000.19621]
266. Keshavarzian, A. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats / A. Keshavarzian, S. Choudhary, E. W. Holmes et al. / J Pharmacol Exp Ther. 2001; 299: 442–448 [PMID: 11602653]
267. Keshavarzian, A. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats / A. Keshavarzian, A. Farhadi, C. B. Forsyth et al. // J Hepatol. 2009; 50: 538–547 [PMID: 19155080 DOI: 10.1016 / j.jhep.2008.10.028
268. Lambert, J. C. Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice / J. C. Lambert, Z. Zhou, L. Wang et al. // J Pharmacol Exp Ther2003; 305: 880–886 [PMID: 12626662 DOI: 10.1124 / jpet.102.047852]
269. Harnisch, J. P. Diphtheria among alcoholic urban adults. A decade of experience in Seattle / J. P. Harnisch, E. Tronca // Ann Intern Med. 1989; 111: 71–82 [PMID: 2472081]
270. Cericco, M. Corynebacterium xerosis endocarditis associated with alcoholic cirrhosis / M. Cericco, F. Iglicki, M. P. Guillaumont et al. // Gastroenterol Clin Biol. 1996; 20: 514 [PMID: 8761156]
271. Salaspuro, V. Ethanol oxidation and acetaldehyde production in vitro by human intestinal strains of Escherichia coli under aerobic, microaerobic, and anaerobic conditions / V. Salaspuro, S. Nyfors, R. Heine et al. // Scand J Gastroenterol. 1999; 34: 967–973 [PMID: 10563665]
272. Tillonen, J. Role of catalase in in vitro acetaldehyde formation by human colonic contents / J. Tillonen, P. Kaihovaara, H. JousimiesSomer et al. // Alcohol Clin Exp Res. 1998; 22: 1113–1119 [PMID: 9726283]
273. DuPont, H. L. Рифаксимин: неабсорбирующийся противомикробный препарат в терапии диареи путешественников / H. L. DuPont, C. D. Ericsson, J. J. Mathewson // Гастроnewsлайн. – 2014. – № 5. – С. 5–10.
274. Corazza, G. R. Treatment Of functional bowel disoders: is there room for antibiotics? / G. R. Corazza, M. Di Stefauo, C. Sparpignato // Digestion 2006; 73 (Suppl. 1): 38–46.
275. Kerlin, P. Glucose-H2 breath test for small intestinal bacterial overgrowth / P. Kerlin // Gastroenterology. 1990; 98: 253–4.